Search Results 1271-1280 of 18399 for Measles
placebo in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate-to-severe epistaxis who require parenteral iron infusions or blood ...
Share · Tweet . IMG-20077546. Home; espanol-historiasmayo-8coljpg. Fuel groundbreaking medical research! Give Today. Your donation powers the future of ...
Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Rubella Virus Vaccine, Live; Smallpox Monkeypox Vaccine; Typhoid Vaccine; Varicella Virus Vaccine, Live ...
Felicity T. Enders, Ph.D., a leading biostatistician at Mayo Clinic, advances research education, population health and workforce development.
The purpose of this study is to determine the RP2D of BNT324 in combination with BNT327 by assessing the safety and tolerability in participants with advanced ...
About this study. Is the treatment strategy of percutaneous left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) superior ...
3X challenge extended through 1/15! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & ...
About this study. To determine if the addition of midostaurin (PKC412) to Standard of Care (SOC) therapy reduces relapse in FLT3-ITD mutated AML patients ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study examines Stress Management and Resilience Training (SMART) for family caregivers (FCG) of patients receiving chemotherapy for advanced cancer to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.